The Ubiquitin Proteasome System in Neurodegenerative Diseases Sometimes the Chicken, Sometimes the Egg
暂无分享,去创建一个
[1] K. Wada,et al. Loss of Uch-L1 and Uch-L3 leads to neurodegeneration, posterior paralysis and dysphagia. , 2001, Human molecular genetics.
[2] J. C. Greene,et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[3] Jeffrey N Keller,et al. The proteasome in brain aging , 2002, Ageing Research Reviews.
[4] J. Valentine,et al. Misfolded CuZnSOD and amyotrophic lateral sclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] K. Lindsten,et al. A transgenic mouse model of the ubiquitin/proteasome system , 2003, Nature Biotechnology.
[6] N. Hattori,et al. An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin , 2001, Cell.
[7] MoonHee Lee,et al. Effect of the overexpression of wild‐type or mutant α‐synuclein on cell susceptibility to insult , 2001 .
[8] L. Bruijn,et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.
[9] T. Dawson,et al. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] K. Lindenberg,et al. Protein surveillance machinery in brains with spinocerebellar ataxia type 3: Redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions , 2002, Annals of neurology.
[11] M. Mancini,et al. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components , 2002, Nature Cell Biology.
[12] D. Rubinsztein,et al. Transcriptional abnormalities in Huntington disease. , 2003, Trends in genetics : TIG.
[13] R. Kopito,et al. Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.
[14] David R. Brown. Copper and prion disease , 2001, Brain Research Bulletin.
[15] A. Abeliovich,et al. Parkin Is a Component of an SCF-like Ubiquitin Ligase Complex and Protects Postmitotic Neurons from Kainate Excitotoxicity , 2003, Neuron.
[16] N. Weigel,et al. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. , 1999, Human molecular genetics.
[17] N. Thakor,et al. Parkin Facilitates the Elimination of Expanded Polyglutamine Proteins and Leads to Preservation of Proteasome Function* , 2003, Journal of Biological Chemistry.
[18] J. Julien,et al. Amyotrophic Lateral Sclerosis Unfolding the Toxicity of the Misfolded , 2001, Cell.
[19] C. Ross,et al. Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease , 2001, Nature Medicine.
[20] A. Matouschek,et al. Aggregated and Monomeric α-Synuclein Bind to the S6′ Proteasomal Protein and Inhibit Proteasomal Function* , 2003, The Journal of Biological Chemistry.
[21] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[22] S. Tsuji,et al. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch , 1998, Nature Genetics.
[23] S. Jentsch,et al. A Novel Ubiquitination Factor, E4, Is Involved in Multiubiquitin Chain Assembly , 1999, Cell.
[24] V. Lee,et al. Are Ubiquitination Pathways Central to Parkinson's Disease? , 2003, Cell.
[25] R. Kopito,et al. Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.
[26] J. Satoh,et al. A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population , 2001, Journal of the Neurological Sciences.
[27] Naoyuki Taniguchi,et al. Dorfin Ubiquitylates Mutant SOD1 and Prevents Mutant SOD1-mediated Neurotoxicity* , 2002, The Journal of Biological Chemistry.
[28] Georg Auburger,et al. The ubiquitin pathway in Parkinson's disease , 1998, Nature.
[29] H. Lehrach,et al. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. , 2001, Molecular biology of the cell.
[30] F. Grosveld,et al. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. , 1998, Science.
[31] C. Ross,et al. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. , 2003, Human molecular genetics.
[32] I. Kanazawa,et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. , 2001, Human molecular genetics.
[33] Junying Yuan,et al. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders , 2003, Nature.
[34] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[35] P. Lockhart,et al. Parkin Protects against the Toxicity Associated with Mutant α-Synuclein Proteasome Dysfunction Selectively Affects Catecholaminergic Neurons , 2002, Neuron.
[36] R. S. Stewart,et al. Mutant PrP Is Delayed in Its Exit from the Endoplasmic Reticulum, but Neither Wild-type nor Mutant PrP Undergoes Retrotranslocation Prior to Proteasomal Degradation* , 2003, Journal of Biological Chemistry.
[37] Pascal Kahlem,et al. Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease. , 2002, Journal of cell science.
[38] M. Franceschi,et al. Protein misfolding in Alzheimer’s and Parkinson’s disease: genetics and molecular mechanisms , 2002, Neurobiology of Aging.
[39] G. Rotilio,et al. Proteasome activation and nNOS down‐regulation in neuroblastoma cells expressing a Cu,Zn superoxide dismutase mutant involved in familial ALS , 2003, Journal of neurochemistry.
[40] C. Warren Olanow,et al. Altered Proteasomal Function in Sporadic Parkinson's Disease , 2003, Experimental Neurology.
[41] S. Lindquist,et al. Neurotoxicity and Neurodegeneration When PrP Accumulates in the Cytosol , 2002, Science.
[42] R. Nitsch,et al. Proteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer's disease , 2003, Journal of neurochemistry.
[43] R. Bowser,et al. The septin CDCrel-1 binds syntaxin and inhibits exocytosis , 1999, Nature Neuroscience.
[44] T. Chase,et al. Degradation of α-Synuclein by Proteasome* , 1999, The Journal of Biological Chemistry.
[45] C. Pickart,et al. Mechanisms underlying ubiquitination. , 2001, Annual review of biochemistry.
[46] Moonhee Lee,et al. Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins , 2003, Journal of neurochemistry.
[47] E. Hol,et al. Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression , 2003, Journal of neurochemistry.
[48] Harry T Orr,et al. Mutation of the E6-AP Ubiquitin Ligase Reduces Nuclear Inclusion Frequency While Accelerating Polyglutamine-Induced Pathology in SCA1 Mice , 1999, Neuron.
[49] M. Rechsteiner,et al. Are Huntington's and polyglutamine-based ataxias proteasome storage diseases? , 2003, The international journal of biochemistry & cell biology.
[50] N. Hattori,et al. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin‐like domain , 2003, EMBO reports.
[51] Albert Taraboulos,et al. Proteasomes and ubiquitin are involved in the turnover of the wild‐type prion protein , 2001, The EMBO journal.
[52] W. V. Van Nostrand,et al. Amyloid β-Protein Inhibits Ubiquitin-dependent Protein Degradation in Vitro(*) , 1995, The Journal of Biological Chemistry.
[53] J. Culvenor,et al. α-synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy , 2003, Experimental Neurology.
[54] E. Hol,et al. Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[55] R. Hen,et al. Proteasomal-Dependent Aggregate Reversal and Absence of Cell Death in a Conditional Mouse Model of Huntington's Disease , 2001, The Journal of Neuroscience.
[56] James F. Gusella,et al. Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease , 2000, Nature Reviews Neuroscience.
[57] René Hen,et al. Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.
[58] E. Hol,et al. Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation , 2002, The Journal of cell biology.
[59] H. Palmer,et al. Age-related decline in ubiquitin conjugation in response to oxidative stress in the lens. , 1997, Experimental eye research.
[60] T. Hashikawa,et al. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. , 2002, Molecular cell.
[61] D. R. Brown. Copper and prion diseases. , 2001, Biochemical Society transactions.
[62] J. Pasquini,et al. Defective ubiquitination of cerebral proteins in Alzheimer's disease , 2000, Journal of neuroscience research.
[63] T. Flatmark,et al. Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form. , 2002, European journal of biochemistry.
[64] Christopher A Ross,et al. Polyglutamine Pathogenesis Emergence of Unifying Mechanisms for Huntington's Disease and Related Disorders , 2002, Neuron.
[65] D. Wolf,et al. For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin–proteasome connection , 2003, The EMBO journal.
[66] G. Melino,et al. ‘Tissue’ transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease , 2002, Cell Death and Differentiation.
[67] H. Zoghbi,et al. Identification of genes that modify ataxin-1-induced neurodegeneration , 2000, Nature.
[68] E. K. Hoffman,et al. Proteasome inhibition enhances the stability of mouse Cu Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis , 1996, Journal of the Neurological Sciences.
[69] J. Adams,et al. The proteasome: structure, function, and role in the cell. , 2003, Cancer treatment reviews.
[70] David W. Miller,et al. L166P Mutant DJ-1, Causative for Recessive Parkinson's Disease, Is Degraded through the Ubiquitin-Proteasome System* , 2003, Journal of Biological Chemistry.
[71] V. Bindokas,et al. No correlation between aggregates of Cu/Zn superoxide dismutase and cell death in familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.
[72] E. Hirsch,et al. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. , 2003, Human molecular genetics.
[73] C A Ross,et al. Intranuclear Neuronal Inclusions: A Common Pathogenic Mechanism for Glutamine-Repeat Neurodegenerative Diseases? , 1997, Neuron.
[74] A. Ciechanover,et al. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.
[75] Bruce A. Yankner,et al. Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease , 2002, Nature Medicine.
[76] M. F. Perutz,et al. Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats , 2001, Nature.
[77] Daniel R. Scoles,et al. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. , 2003, Human molecular genetics.
[78] S. Ferrari,et al. Proteasomal Degradation and N-terminal Protease Resistance of the Codon 145 Mutant Prion Protein* , 1999, The Journal of Biological Chemistry.
[79] H. Lehrach,et al. Mutant Huntingtin Promotes the Fibrillogenesis of Wild-type Huntingtin , 2003, Journal of Biological Chemistry.
[80] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[81] C. Pickart,et al. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[82] B. Sommer,et al. Part I: Parkin-associated proteins and Parkinson’s disease , 2003, Neuropharmacology.
[83] M. Figueiredo-Pereira,et al. Ubiquitin, cellular inclusions and their role in neurodegeneration , 1998, Trends in Neurosciences.
[84] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[85] A. Weissman,et al. RING Finger Proteins Mediators of Ubiquitin Ligase Activity , 2000, Cell.
[86] Bonifati,et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. , 2000, The New England journal of medicine.
[87] K. Hofmann,et al. When ubiquitin meets ubiquitin receptors: a signalling connection , 2003, Nature Reviews Molecular Cell Biology.
[88] Nobutaka Hattori,et al. Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease , 2001, Science.
[89] A. Aguzzi,et al. Mice devoid of PrP are resistant to scrapie , 1993, Cell.
[90] N. Taniguchi,et al. Gain in functions of mutant Cu,Zn-superoxide dismutases as a causative factor in familial amyotrophic lateral sclerosis: Less reactive oxidant formation but high spontaneous aggregation and precipitation , 2000, Free radical research.
[91] A. Ciechanover,et al. Ubiquitin-dependent Degradation of Certain Protein Substrates in Vitro Requires the Molecular Chaperone Hsc70* , 1997, The Journal of Biological Chemistry.
[92] Bryan L Roth,et al. Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons* , 2003, Journal of Biological Chemistry.
[93] H. Paulson,et al. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. , 1999, Human molecular genetics.
[94] M. Porteous,et al. Dentatorubral and pallidoluysian atrophy (DRPLA) Clinical and neuropathological findings in genetically confirmed north american and european pedigrees , 1997, Movement disorders : official journal of the Movement Disorder Society.
[95] Wendy Bruening,et al. Up‐Regulation of Protein Chaperones Preserves Viability of Cells Expressing Toxic Cu/Zn‐Superoxide Dismutase Mutants Associated with Amyotrophic Lateral Sclerosis , 1999, Journal of neurochemistry.
[96] D. Sulzer,et al. Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. , 2001, Human molecular genetics.
[97] T. de Cristofaro,et al. The length of polyglutamine tract, its level of expression, the rate of degradation, and the transglutaminase activity influence the formation of intracellular aggregates. , 1999, Biochemical and biophysical research communications.
[98] Xiaoling Wang,et al. Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor. , 2003, Human molecular genetics.
[99] D. Sulzer,et al. Autophagy in neurons: a review. , 2002, Histology and histopathology.
[100] M. Gurney,et al. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[101] Sawsan Youssef,et al. Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine , 2002, Nature Medicine.
[102] Y. Imai,et al. Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity* , 2000, The Journal of Biological Chemistry.
[103] Steven Finkbeiner,et al. Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.
[104] W. Baumeister,et al. The 26S proteasome: a molecular machine designed for controlled proteolysis. , 1999, Annual review of biochemistry.
[105] K. Lindenberg,et al. Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. , 2002, Molecular cell.
[106] J. Morrison,et al. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis. , 1998, The Journal of experimental zoology.
[107] Patrik Brundin,et al. Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein , 2002, Nature Reviews Neuroscience.
[108] Vidya N. Nukala,et al. Characterization of chronic low‐level proteasome inhibition on neural homeostasis , 2003, Journal of neurochemistry.
[109] W. Markesbery,et al. Impaired Proteasome Function in Alzheimer's Disease , 2000, Journal of neurochemistry.
[110] M. Hayden,et al. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. , 2003, Brain : a journal of neurology.
[111] A. Goldberg,et al. Cellular Defenses against Unfolded Proteins A Cell Biologist Thinks about Neurodegenerative Diseases , 2001, Neuron.
[112] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[113] P. Lansbury,et al. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.
[114] S. Minotti,et al. Mutant Cu/Zn-Superoxide Dismutase Proteins Have Altered Solubility and Interact with Heat Shock/Stress Proteins in Models of Amyotrophic Lateral Sclerosis* , 2001, The Journal of Biological Chemistry.
[115] C. van Broeckhoven,et al. Association of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex. , 2001, Human molecular genetics.
[116] L. Serpell,et al. Proteasomal degradation of tau protein , 2002, Journal of neurochemistry.
[117] E A Zemskov,et al. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. , 2001, Human molecular genetics.
[118] K. Lindsten,et al. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins. , 2002, Human molecular genetics.
[119] W. Dalton,et al. The proteasome. , 2004, Seminars in oncology.
[120] G. Sobue,et al. Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis. , 2003, The American journal of pathology.
[121] Andrea Crotti,et al. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes , 2003, Nature Genetics.
[122] V. Buchman,et al. Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease , 2003, Neuropharmacology.
[123] L. Pasquini,et al. Relationship between β-amyloid degradation and the 26S proteasome in neural cells , 2003, Experimental Neurology.
[124] P. Thomas,et al. Activity and Regulation of the Centrosome-associated Proteasome* , 2000, The Journal of Biological Chemistry.
[125] W. G. Johnson,et al. Ataxin-3 Interactions with Rad23 and Valosin-Containing Protein and Its Associations with Ubiquitin Chains and the Proteasome Are Consistent with a Role in Ubiquitin-Mediated Proteolysis , 2003, Molecular and Cellular Biology.
[126] A. Bruce-Keller,et al. Polyglutamine Expansion, Protein Aggregation, Proteasome Activity, and Neural Survival* , 2002, The Journal of Biological Chemistry.
[127] J. Hodgson,et al. Huntingtin Is Ubiquitinated and Interacts with a Specific Ubiquitin-conjugating Enzyme* , 1996, The Journal of Biological Chemistry.
[128] S. Pulst,et al. Parkin is associated with actin filaments in neuronal and nonneural cells , 2000, Annals of neurology.
[129] N. Hattori,et al. Parkin and Parkinson's disease , 2001, Current opinion in neurology.
[130] D. Cleveland,et al. Oxidation versus aggregation — how do SOD1 mutants cause ALS? , 2000, Nature Medicine.
[131] Hiroyoshi Ariga,et al. DJ-1 Positively Regulates the Androgen Receptor by Impairing the Binding of PIASxα to the Receptor* , 2001, The Journal of Biological Chemistry.
[132] C. Olanow,et al. Selective loss of 20S proteasome α-subunits in the substantia nigra pars compacta in Parkinson's disease , 2002, Neuroscience Letters.
[133] Jean-François Deleuze,et al. Complex relationship between Parkin mutations and Parkinson disease. , 2002, American journal of medical genetics.
[134] C. Olanow,et al. Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson's disease , 2003, Annals of neurology.
[135] E. Hol,et al. Molecular misreading: a new type of transcript mutation expressed during aging , 2000, Neurobiology of Aging.
[136] S. Hersch,et al. Therapeutic Effects of Cystamine in a Murine Model of Huntington's Disease , 2002, The Journal of Neuroscience.
[137] N. Marceau,et al. Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin. , 2001, Experimental and molecular pathology.
[138] N. Hooper. Could inhibition of the proteasome cause mad cow disease? , 2003, Trends in biotechnology.
[139] Isao Nishimura,et al. Parkin Suppresses Dopaminergic Neuron-Selective Neurotoxicity Induced by Pael-R in Drosophila , 2003, Neuron.
[140] T. Dawson,et al. Rare genetic mutations shed light on the pathogenesis of Parkinson disease. , 2003, The Journal of clinical investigation.
[141] G. Sobue,et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy , 2003, Nature Medicine.
[142] R. Takahashi,et al. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.
[143] Orla Hardiman,et al. “True” sporadic ALS associated with a novel SOD‐1 mutation , 2002, Annals of neurology.
[144] Aaron Ciechanover,et al. The ubiquitin-proteasome proteolytic pathway , 1994, Cell.
[145] R. Kaufman. Orchestrating the unfolded protein response in health and disease. , 2002, The Journal of clinical investigation.
[146] Elena Cattaneo,et al. Loss of normal huntingtin function: new developments in Huntington's disease research , 2001, Trends in Neurosciences.
[147] K. McNaught,et al. Proteasomal function is impaired in substantia nigra in Parkinson's disease , 2001, Neuroscience Letters.
[148] C. Sigurdson,et al. [Prion diseases?]. , 1985, Deutsche medizinische Wochenschrift.
[149] Arunandan Kumar,et al. The Chaperone Protein BiP Binds to a Mutant Prion Protein and Mediates Its Degradation by the Proteasome* , 2000, The Journal of Biological Chemistry.
[150] P. Lansbury,et al. The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease Susceptibility , 2002, Cell.
[151] K. Fischbeck,et al. Toxic Proteins in Neurodegenerative Disease , 2002, Science.
[152] G. Sobue,et al. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords – screening by molecular indexing and subsequent cDNA microarray analysis , 2002, FEBS letters.
[153] S. Prusiner. Novel proteinaceous infectious particles cause scrapie. , 1982, Science.
[154] H. Green,et al. Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[155] H. Zoghbi,et al. Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.
[156] S E Ide,et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.
[157] Takayuki Harada,et al. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice , 1999, Nature Genetics.
[158] Hans Lehrach,et al. Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo , 1997, Cell.
[159] S. Lindquist,et al. Conversion of PrP to a Self-Perpetuating PrPSc-like Conformation in the Cytosol , 2002, Science.
[160] Sudarshan C. Upadhya,et al. A potential proteasome-interacting motif within the ubiquitin-like domain of parkin and other proteins. , 2003, Trends in biochemical sciences.
[161] M. Gurney,et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[162] Zhao-Xue Yu,et al. Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity , 2003, The Journal of cell biology.